Final program > International meeting
International program ( Presentations will be in English) Tuesday September 20
8:15 - 9:00 Welcome and registration of the participants
9:00 - 9:15 Présentation du Forum ACCITH 2011 par Hervé WATIER et Jean-Yves BONNEFOY
9:15 - 12:15 Session « Antibody selection »
Chairmen: Franck PEREZ, Philippe MONDON
- 9:15 - 10:00 Andrew GRIFFITHS Institut de science et d’ingénierie supramoléculaires (ISIS), Strasbourg
Comparing tools for antibody screening
- 10:00 - 10:30 Pierre MARTINEAU Institut de recherche en cancérologie de Montpellier (IRCM)
Montpellier
Tailoring antibody libraries for diversity, expression and affinity
10:30 - 11:00 Coffee break
- 11:00 - 11:45 André TRAUNECKER Novartis Pharma, Bâle, Suisse
NIBR mouse - A personal journey from magic bullet to therapeutic magic bullet
- 11:45 - 12:15 Michel COGNÉ Physiologie moléculaire de la réponse immune et des lymphoproliférations,
Limoges
In vitro and in vivo evaluation of anti-CD20 chimeric antibodies shows the
IgA-class to surpass IgG for direct effect on target cells
12:15 - 14:00 Lunch
14:00 - 18:15 Session « Antibody engineering and preclinical assessment » - Part 1
Chairmen: Philippe ANCIAN, André PELEGRIN
- 14:00 - 14:45 Stefan DÜBEL University of Braunschweig, Germany
Improved recombinant antibodies for research, diagnostics and therapy
- 14:45 - 15:30 Frédéric DUCANCEL Institut de biologie et de technologies de Saclay, CEA, Gif-sur-Yvette
Antibody engineering for therapy and imaging
15:30 - 15:45 Coffee break
- 15:45 - 16:30 Alain BECK Centre d’immunologie Pierre Fabre (CIPF), Saint-Julien en Genevois
Therapeutic antibodies structural characterization and optimization
- 16:30 - 17:15 Jean-Luc TEILLAUD Biotechnologie des anticorps, Centre de recherche des Cordeliers,
Paris
Long-lasting antitumor protection by anti-CD20 antibody through cellular
adaptive immune response
- 17:15 - 17:35 Hélène HAEGEL Transgene, Illkirch
Development of an antibody with multiple intervention points for cancer
therapy
- 17:35 - 17:55 Mireia PELEGRIN Institut de génétique moléculaire, Montpellier
Vaccine-like effects of neutralizing monoclonal antibodies: a crucial role for
infected-cell/antibody immune complexes in the enhancement of endogenous
antiviral immunity by short passive immunotherapy
- 17:55 - 18:25 Philippe THUILLIER Unité de biotechnologie des anticorps et des toxines, CRSSA-IRBA,
La Tronche
Germline-humanization: toward the fourth generation of recombinant
antibodies
18:25 - 19:30 Poster session (Refreshments)
19:30 - 20:15 Invited Lecture
Introduction of the guest speaker by Étienne WEISS
Marc VAN REGENMORTEL Biotechnologie et signalisation cellulalre, Illkirch
Antigens, immunogens and HIV-1 vaccine design
20:15 Gala dinner
Wednesday September 21
9:00 - 9:45 Session « Antibody engineering and preclinical assessment » - Part 2
Chairpersons : Martine CERUTTI, Thierry WURCH
- 9:00 - 9:15 Naima ABIDI-AZZOUZ Centre de recherches de biochimie macromoléculaire, Montpellier
Nanobodies based on a dromedary single-domain antibody targeting the reverse
transcriptase of HIV-1
- 9:15 - 9:30 Marie VINCENT Centre de recherche en cancérologie, Nantes
Development of two IL15 immunocytokines targeting either GD2- or CD20-
tumoral bearing cells
- 9:30 - 9:45 Patricia ROUSSELLE Institut de biologie et chimie des protéines, Lyon
Adhesio-mAb: a anti-laminin monoclonal antibody for cancer therapy
9:45 - 13:15 Session « Antibody bioproduction »
Chairpersons: Martine CERUTTI, Thierry WURCH
- 9:45 - 10:30 Yannick SORLET Novartis Pharma, Huningue
Insights and challenges related to a large scale, multipurpose mAb
manufacturing facility - 10:30 - 11:15 Roland BELIARD Laboratoire Français Fractionnement Biotechnologies (LFB), Paris
Challenges and issues in the development of biologicals: from the lead molecule
to the marketed product
11:15 - 11:45 Coffee break
- 11:45 - 12:30 Ralf RESKI Université de Fribourg, Allemagne
Antibody production in moss bioreactors
- 12:30 - 13:15 Table ronde
Sylviane MULLER (UPR 9021, Strasbourg) et Hervé WATIER, Président du GDR
Download the final program for printing
|
